SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039392
Filing Date
2022-02-14
Accepted
2022-02-14 07:17:29
Documents
4
Group Members
ASHVIN B. CHHABRAGREENLAND A LLCGREENLAND FP LLCGREENLAND NFP B LTD.GREENLAND NFP LLCJAMES H. SIMONSMARILYN H. SIMONSSYMMETRY GROUP LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d310571dsc13ga.htm SC 13G/A 138502
2 EX-99.1 d310571dex991.htm EX-99.1 7857
3 EX-99.2 d310571dex992.htm EX-99.2 7855
4 EX-99.3 d310571dex993.htm EX-99.3 7857
  Complete submission text file 0001193125-22-039392.txt   163708
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Subject) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91714 | Film No.: 22625163
SIC: 2834 Pharmaceutical Preparations

Mailing Address 160 FIFTH AVE, 9TH FL NEW YORK NY 10010
Business Address 160 FIFTH AVE, 9TH FL NEW YORK NY 10010 212-537-0335
Euclidean Capital LLC (Filed by) CIK: 0001825034 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A